Dermatology

The AJMC® Dermatology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the skin, hair, and nails.

Evaluating Factors Associated With Treatment Satisfaction in Hidradenitis Suppurativa

September 24th 2022, 7:20pm

Article

Tobacco smoking, depression, and increasing number of comorbidities were associated with reduced treatment satisfaction among patients with hidradenitis suppurativa.

Advocate Discusses Surgical, Therapeutic Management of Hidradenitis Suppurativa

September 23rd 2022, 1:20pm

Video

Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected by hidradenitis suppurativa (HS), spoke on the surgical and therapeutic interventions she’s had for the management of HS.

Advocate Details Challenges Faced in Path to Diagnosis for Hidradenitis Suppurativa

September 16th 2022, 2:40pm

Video

Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected by hidradenitis suppurativa (HS), discussed the misconceptions she faced from clinicians regarding her clinical symptoms of HS prior to diagnosis.

Secukinumab Shows Rapid, Sustained Improvement of Hidradenitis Suppurativa

September 14th 2022, 6:30pm

Article

SUNSHINE and SUNRISE trial data will be submitted to the FDA as part of Novartis’ Biologics License Application (BLA) for secukinumab in hidradenitis suppurativa.

Advocate Discusses Physical, Psychological Impact of Hidradenitis Suppurativa

September 9th 2022, 7:10pm

Video

Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected with hidradenitis suppurativa (HS), speaks on the quality of life burden she has experienced during her HS disease journey.

Shared Decision-Making Linked With Improved Treatment Satisfaction in Alopecia Areata

September 8th 2022, 6:40pm

Article

Patients with alopecia areata were less likely to report decisional regret regarding treatment when dermatologists incorporated shared decision-making, with prescription of Janus kinase (JAK) inhibitors associated with the lowest decisional regret.

Pain and Late Onset of Hidradenitis Suppurativa May Affect Employment, Educational Level

September 3rd 2022, 6:20pm

Article

Inactive occupational status and low educational level were associated with pain, late disease onset, and greater number of affected areas in patients with hidradenitis suppurativa.

Advocate Highlights Misconceptions in the Management of Hidradenitis Suppurativa

August 27th 2022, 5:10pm

Video

Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected by hidradenitis suppurativa (HS), spoke on misconceptions she’s encountered on her HS disease journey and the importance for physicians to be conscientious of their advice to patients.

Clinical Features, Management of Acne Fulminans Explored in New Case Report

August 24th 2022, 5:03pm

Article

A case report of a patient with acne fulminans, a rare form of acne vulgaris, discussed the clinical manifestations of the disease, physical examination findings, and management strategies.

Advocate Speaks on Critical Research Needs in Hidradenitis Suppurativa

August 20th 2022, 6:05pm

Video

Brindley Brooks, who founded HS Connect (HSconnect.org), a patient advocacy group for those affected with hidradenitis suppurativa (HS), spoke on key areas of HS comprehension and management that warrant further investigation in clinical research.